Chitosan Microspheres Containing Bordetella bronchiseptica Antigens as Novel Vaccine Against Atrophic Rhinitis in Pigs |
Kang, Mi-Lan
(Department of Infectious Diseases, College of Veterinary Medicine, KRF Zoonotic Disease Priority Research Institute and BK21 Program for Veterinary Science, Seoul National University)
Kang, Sang-Gyun (Department of Infectious Diseases, College of Veterinary Medicine, KRF Zoonotic Disease Priority Research Institute and BK21 Program for Veterinary Science, Seoul National University) Jiang, Hu-Lin (Department of Agricultural Biotechnology, Seoul National University) Guo, Ding-Ding (Department of Agricultural Biotechnology, Seoul National University) Lee, Deog-Yong (Department of Infectious Diseases, College of Veterinary Medicine, KRF Zoonotic Disease Priority Research Institute and BK21 Program for Veterinary Science, Seoul National University) Rayamahji, Nabin (Department of Infectious Diseases, College of Veterinary Medicine, KRF Zoonotic Disease Priority Research Institute and BK21 Program for Veterinary Science, Seoul National University) Seo, Yeon-Soo (Department of Infectious Diseases, College of Veterinary Medicine, KRF Zoonotic Disease Priority Research Institute and BK21 Program for Veterinary Science, Seoul National University) Cho, Chong-Su (Department of Agricultural Biotechnology, Seoul National University) Yoo, Han-Sang (Department of Infectious Diseases, College of Veterinary Medicine, KRF Zoonotic Disease Priority Research Institute and BK21 Program for Veterinary Science, Seoul National University) |
1 | Aksungur, P., A. Sungur, S. Unal, A. B. Iskit, C. A. Squier, and S. Senel. 2004. Chitosan delivery systems for the treatment of oral mucositis: In vitro and in vivo studies. J. Control. Release 98: 269-279 DOI ScienceOn |
2 | Bokor-Bratic, M. 2000. Clinical significance of analysis of immunoglobulin A levels in saliva. Med. Pregl. 53: 164-168 |
3 | Chanter, N., T. Magyar, and J. M. Rutter. 1989. Interactions between Bordetella bronchiseptica and toxigenic Pasteurella multocida in atrophic rhinitis of pigs. Res. Vet. Sci. 47: 48-53 |
4 | Davis, S. S. 2001. Nasal vaccines. Adv. Drug Deliv. Rev. 51: 21-42 DOI |
5 | Gavini, E., A. B. Hegge, G. Rassu, V. Sanna, C. Testa, G. Pirisino, J. Karlsen, and P. Giunchedi. 2005. Nasal administration of carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int. J. Pharm. 307: 9-15 DOI ScienceOn |
6 | Jacques, M., N. Parent, and B. Foiry. 1988. Adherence of Bordetella bronchiseptica and Pasteurella multocida to porcine nasal epithelial cells. Can. J. Vet. Res. 52: 283-285 |
7 | Kim, Y. H., K. Y. Cheong, W. S. Shin, S. Y. Hong, H. J. Woo, and M. S. Kwon. 2006. Immunological characterization of full and truncated recombinant clones of ompH(D:4) obtained from Pasteurella multocida (D:4) in Korea. J. Microbiol. Biotechnol. 16: 1529-1536 과학기술학회마을 |
8 | Larsen, D. L., A. Karasin, F. Zuckermann, and C. W. Olsen. 2000. Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Vet. Microbiol. 74: 117-131 DOI |
9 | McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 10: 75-88 DOI ScienceOn |
10 | Schipper, N. G. M., J. C. Verhoef, and F. Merkus. 1991. The nasal mucociliary clearance: Relevance to nasal drug delivery. Pharm. Res. 8: 807-814 DOI ScienceOn |
11 | Senel, S., M. J. Kremer, S. Kas, P. W. Wertz, A. A. Hincal, and C. A. Squier. 2000. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 21: 2067- 2071 DOI ScienceOn |
12 | Kang, M. L., S. G. Kang, H. L. Jiang, S. W. Shin, D. Y. Lee, J. M. Ahn, N. Rayamahji, I. K. Park, S. J. Shin, C. S. Cho and H. S. Yoo. 2006. In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT. Eur. J. Pharm. Biopharm. 63: 215-220 DOI ScienceOn |
13 | Foged, N. T. 1992. Pasteurella multocida toxin. The characterization of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs. APMIS Suppl. 25: 1-56 |
14 | Francisco, C. J., T. R. Shryock, D. P. Bane, and L. Unverzagt. 1996. Serum haptoglobin concentration in growing swine after intranasal challenge with Bordetella bronchiseptica and toxigenic Pasteurella multocida type D. Can. J. Vet. Res. 60: 222-227 |
15 | Kang, S. W., E. R. Cho, and B. S. Kim. 2005. PLGA microspheres in hyaluronic acid gel as a potential bulking agent for urologic and dermatologic injection therapies. J. Microbiol. Biotechnol. 15: 510-518 과학기술학회마을 |
16 | de Jong, M. F. 1987. Prevention of atrophic rhinitis in piglets by means of intranasal administration of a live non-AR-pathogenic Bordetella bronchiseptica vaccine. Vet. Q. 9: 123-133 DOI ScienceOn |
17 | Pereswetoff-Morath, L. 1998. Microspheres as nasal drug delivery system. Adv. Drug Deliv. Rev. 29: 185-194 DOI |
18 | Jiang, H. L., I. K. Park, N. R. Shin, S. G. Kang, H. S. Yoo, S. I. Kim, S. B. Suh, T. Akaike, and C. S. Cho. 2004. In vitro study of the immune stimulating activity of an atrophic rhinitis vaccine associated to chitosan microspheres. Eur. J. Pharm. Biopharm. 58: 471-476 DOI ScienceOn |
19 | Gatlin, C. L., W. H. Jordan, T. R. Shryock, and W. C. Smith. 1996. The quantitation of turbinate atrophy in pigs to measure the severity of induced atrophic rhinitis. Can. J. Vet. Res. 60: 121-126 |
20 | To, H., S. Someno, and S. Nagai. 2005. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs. Am. J. Vet. Res. 66: 113-118 DOI ScienceOn |
21 | Challacombe, S. J. 1995. Assessing mucosal humoral immunity. Clin. Exp. Immunol. 100: 181-182 DOI ScienceOn |
22 | Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7: 265-276 DOI |
23 | Sakano, T., K. Sakurai, T. Furutani, and T. Shimizu. 1984. Immunogenicity and safety of an attenuated Bordetella bronchiseptica vaccine in pigs. Am. J. Vet. Res. 45: 1814-1817 |
24 | Ugwoke, M. I., R. U. Agu, N. Verbeke, and R. Kinget. 2005. Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv. Drug Deliv. Rev. 57: 1640- 1665 DOI ScienceOn |
25 | Pedersen, K. B. and F. Elling. 1984. The pathogenesis of atrophic rhinitis in pigs induced by toxigenic Pasteurella multocida. J. Comp. Pathol. 94: 203-214 DOI ScienceOn |
26 | Nakai, T., K. Kume, H. Yoshikawa, T. Oyamada, and T. Yoshikawa. 1988. Adherence of Pasteurella multocida or Bordetella bronchiseptica to the swine nasal epithelial cell in vitro. Infect. Immun. 56: 234-240 |
27 | Rutter, J. M. 1985. Atrophic rhinitis in swine. Adv. Vet. Sci. Comp. Med. 29: 239-279 |
28 | Donovan, M. D., G. L. Flynn, and G. L. Amidon. 1990. Absorption of polyethylene glycols 600 through 2000: The molecular weight dependence of gastrointestinal and nasal absorption. Pharm. Res. 7: 863-868 DOI ScienceOn |
29 | He, P., S. S. Davis, and L. Illum. 1998. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166: 75-88 DOI ScienceOn |
30 | Varshosaz, J., H. Sadrai, and R. Alinagari. 2004. Nasal delivery of insulin using chitosan microspheres. J. Microencapsul. 21: 761-774 DOI ScienceOn |
31 | Sarkar, M. A. 1992. Drug metabolism in the nasal mucosa. Pharm. Res. 9: 1-9 DOI ScienceOn |
32 | Shin, N. R., I. S. Choi, J. M. Kim, W. Hur, and H. S. Yoo. 2002. Effective methods for the production of immunoglobulin Y using immunogens of Bordetella bronchiseptica, Pasteurella multocida and Actinobacillus pleuropneumoniae. J. Vet. Sci. 3: 47-57 |
33 | Sankar, C., M. Rani, A. K. Srivastava, and B. Mishra. 2001. Chitosan based pentazocine microspheres for intranasal systemic delivery: Development and biopharmaceutical evaluation. Pharmazie 56: 223-226 |
34 | Park, I. K., H. L. Jiang, C. H. Yun, Y. J. Choi, S. J. Kim, T. Akaike, S. I. Kim, and C. S. Cho. 2004. Release of Newcastle disease virus vaccine from chitosan microspheres in vitro and in vivo. Asian Austral. J. Anim. Sci. 17: 543-547 DOI |
35 | Partidos, C. D. 2000. Intranasal vaccines: Forthcoming challenges. Pharm. Sci. Technolo. Today 3: 273-281 DOI ScienceOn |